Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
12
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.20 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise
model 55%
• Critical: only 0.2 months cash remaining
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$1.66M
Shares Outstanding8.10M
Float7.68M
Cash$213.6K
Debt$1.20M
Short InterestN/A
Institutional Holdings
1 institutional holders · 7 shares
#1
Guerra Advisors Inc
7 shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest141.6K
Days to Cover7.0
% of Float1.8%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-07-08
xbrl
XBRL CONVERTIBLE
2022-12-12
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual ZVSA Dilution Snapshot
ZyVersa Therapeutics, Inc. (ZVSA) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for ZVSA: xbrl on 2025-07-08; xbrl on 2022-12-12.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: